Common TitleBRIGHTE
Official Title A Multi-arm Phase 3 Randomized Placebo Controlled Double Blind Clinical Trial to Investigate the Efficacy and Safety of Fostemsavir (BMS-663068) in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1
Phase Phase III
ClinicalTrials.gov NCT02362503
Treatments
Fostemsavir
Fostemsavir
Tradename:RukobiaOther Names:FTRClass:Entry InhibitorsCategories Resistance/Virological FailureTreatment-Experienced
Funding
IndustryBristol-Myers Squibb
References
- Kozal M, Aberg J, Pialoux G, et al. Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection. N Engl J Med. 2020;382:1232-43.